Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Series A Funding
Sort By
Newest First
1 / 1
1 / 1
Series A Funding
Wheeler Bio Announces Initial Closing of Series A Round Supporting New Biologics Drug Substance GMP Expansion In Oklahoma
Wheeler Bio
PR-M10-22-02
Oct 05, 2022
Series A Funding
Biofidelity Raises $23M in Series A+ Financing Led by Octopus Ventures to Launch ASPYRE Technology
Biofidelity
PR-M02-22-04
Feb 07, 2022
Series A
Stemson Therapeutics Secures $15M Series A Funding to Cure Hair Loss
Stemson Therapeutics
PR-M07-21-010
Jul 21, 2021
Stem Cells
Curi Bio Raises $6M Series A Financing Round for iPSC-derived Predictive Platforms
Curi Bio
PR-M03-21-004-1062
Mar 18, 2021
Financing
Syncona Founds Purespring with £45m in Series A Financing
Syncona Ltd
PR-M11-20-017
Nov 19, 2020
Series A Financing
AI Startup Deep Longevity Launches With Series A Financing and New AI System to Tackle Aging-related Diseases
Deep Longevity
PR-M07-20-NI-022
Jul 15, 2020
Financing
Immuneering Completes $17 Million Series A Financing
Immuneering Corporation
PR-M12-19-NI-023
Dec 16, 2019
Funding
Alizé Pharma 3 Raises €67 Million ($75 million) in Series A from an International Syndicate
Amolyt Pharma
PR-M08-19-NI-014
Aug 06, 2019
Immuno-oncology Startup
Polsky Center for Entrepreneurship and Innovation Supports University of Chicago Professor in Founding Immuno-oncology Startup
The Polsky Center for Entrepreneurship and Innovation
PR-M07-19-NI-047
Jul 17, 2019
Series A Financing
Tangen Biosciences Announces $9 Million Series A Financing to Accelerate Development of Disruptive Molecular Diagnostic Platform
Tangen Biosciences
PR-M06-19-NI-041
Jun 24, 2019
Series A Financing
Syncona founds Quell Therapeutics with £35 million Series A Financing
Syncona Ltd
PR-M05-19-NI-063
May 22, 2019
Funding
BillionToOne Announces $15 Million Series A, Co-Led by Hummingbird and NeoTribe
BillionToOne
PR-M04-19-NI-005-2795
Apr 02, 2019
Investment
Embleema Closes $3.7M Series A Funding Round and Joins Techstars Alchemist Blockchain Accelerator Program
Embleema
PR-M02-19-NI-013
Feb 07, 2019
Financing
Entrada Therapeutics Raises $59 Million Series A to Advance Intracellular Biologics Platform
Entrada Therapeutics
PR-M12-18-NI-081
Dec 27, 2018
